Navigation Links
Global Technologies, Ltd. Announces LOI to Acquire and Merge with Oxygen Orchard, Inc.
Date:6/24/2011

ORCHARD, Texas, June 24, 2011 /PRNewswire/ -- Global Technologies, Ltd. (GTLL), announced today that it has executed a Letter of Intent to acquire and merge with Oxygen Orchard, Inc.

GTLL will acquire 100% of Oxygen Orchard and migrate all its operations to the new entity.  All current management, board, and officers will concurrently resign with execution of the various Definitive Agreements. The Definitive Agreements are expected to be completed within 21 days.

Complete disclosures and updated financials will be posted to the OTC Disclosure Service.

Teri H. Mathis, President and CEO of Oxygen Orchard, Inc., will be the new President and CEO. John M. King will be the new CFO.

The Company will change its name to Oxygen Orchard, Inc.

The Company will release additional announcements describing products, markets, and revenue plans.

About Oxygen Orchard, Inc. (formerly Global Technologies):

Oxygen Orchard, Inc. specializes in the design, manufacture and sale of its patented water oxygenating system. The Company is the industry leader in its product category. Based on medical research and market results, the Company's products provide supplemental oxygen to users, resulting in ailment prevention and enhancement of overall wellness. Oxygen Orchard is a woman-owned business and is currently expanding its operations and product distribution internationally.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the Safe Harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from the expected results.

Contact:
Oxygen Orchard, Inc.
P.O. Drawer A
Orchard, TX 77464
Phone: 713-446-5337
Toll Free: 877-347-7770
Email: invest@oxygenorchard.com
Website: www.oxygenorchard.com


'/>"/>
SOURCE Global Technologies, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elseviers SciVal Funding Expands Globally
2. Reportlinker Adds Global CRO Market: Quantitative Assessment
3. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
4. Ashoka and Boehringer Ingelheim Announce a Global Partnership for "Making More Health"
5. Flextronics Global Services Budapest Receives ISO 13485 Medical Certification
6. Boston Scientific Announces Global Launch of Mustang™ PTA Balloon Catheter
7. Panacea Global, Inc. Files Form 8-K to Announce Name Change; Trading Symbol Changes from MLXG to PANG
8. Reportlinker Adds Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
9. Reportlinker Adds Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
10. Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
11. Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
Breaking Medicine News(10 mins):